Human Papillomavirus 9-valent Vaccine, Recombinant
| Brand name | Gardasil 9 |
|---|---|
| Active ingredient | Human Papillomavirus 9-valent Vaccine, Recombinant |
| Strength | 0.5ML |
| Dosage form | Injection |
| Route | Intramuscular |
| Modality | Biologic |
| FDA approval | December 2014 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.